RhumbLine Advisers’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,484
| Closed | -$4.91K | – | 4368 |
|
|
2023
Q2 | $4.91K | Sell |
1,484
-8,067
| -84% | -$26.7K | ﹤0.01% | 4092 |
|
|
2023
Q1 | $87K | Sell |
9,551
-88
| -0.9% | -$802 | ﹤0.01% | 2870 |
|
|
2022
Q4 | $113K | Buy |
9,639
+306
| +3% | +$3.59K | ﹤0.01% | 2889 |
|
|
2022
Q3 | $198K | Buy |
9,333
+470
| +5% | +$9.97K | ﹤0.01% | 2898 |
|
|
2022
Q2 | $215K | Buy |
8,863
+2,551
| +40% | +$61.9K | ﹤0.01% | 2908 |
|
|
2022
Q1 | $314K | Sell |
6,312
-39
| -0.6% | -$1.94K | ﹤0.01% | 2630 |
|
|
2021
Q4 | $446K | Sell |
6,351
-115
| -2% | -$8.08K | ﹤0.01% | 2557 |
|
|
2021
Q3 | $603K | Buy |
6,466
+136
| +2% | +$12.7K | ﹤0.01% | 2456 |
|
|
2021
Q2 | $636K | Sell |
6,330
-574
| -8% | -$57.7K | ﹤0.01% | 2445 |
|
|
2021
Q1 | $644K | Sell |
6,904
-247
| -3% | -$23K | ﹤0.01% | 2377 |
|
|
2020
Q4 | $590K | Buy |
7,151
+624
| +10% | +$51.5K | ﹤0.01% | 2371 |
|
|
2020
Q3 | $560K | Sell |
6,527
-588
| -8% | -$50.4K | ﹤0.01% | 2238 |
|
|
2020
Q2 | $662K | Buy |
7,115
+3,669
| +106% | +$341K | ﹤0.01% | 2221 |
|
|
2020
Q1 | $98K | Buy |
3,446
+1,080
| +46% | +$30.7K | ﹤0.01% | 2783 |
|
|
2019
Q4 | $98K | Buy |
2,366
+244
| +11% | +$10.1K | ﹤0.01% | 2875 |
|
|
2019
Q3 | $30K | Buy |
2,122
+98
| +5% | +$1.39K | ﹤0.01% | 2942 |
|
|
2019
Q2 | $71K | Buy |
+2,024
| New | +$71K | ﹤0.01% | 2947 |
|
|
2018
Q2 | – | Sell |
-898
| Closed | -$94K | – | 2934 |
|
|
2018
Q1 | $94K | Buy |
898
+310
| +53% | +$32.5K | ﹤0.01% | 2745 |
|
|
2017
Q4 | $75K | Hold |
588
| – | – | ﹤0.01% | 2799 |
|
|
2017
Q3 | $68K | Buy |
588
+22
| +4% | +$2.54K | ﹤0.01% | 2887 |
|
|
2017
Q2 | $74K | Buy |
+566
| New | +$74K | ﹤0.01% | 2911 |
|